Sanofi (SNYNF) Amortizatization of Intangibles (2010 - 2023)
Sanofi (SNYNF) posted Amortizatization of Intangibles of $524.9 million for Q1 2023, up 4.15% sequentially from $503.9 million in Q1 2022, and up 4.15% YoY from $503.9 million in Q1 2022.
Sanofi (SNYNF) Amortizatization of Intangibles (2010 - 2023) Analysis & Trends
Sanofi (SNYNF) has 8 years of Amortizatization of Intangibles data on file, last reported at $524.9 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 1.70 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 931.00 Mn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 596.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Sanofi | - | - | 9.49 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 524.86 Mn |
| Mar 31, 2023 | 524.86 Mn |
| Mar 31, 2022 | 503.93 Mn |
| Mar 31, 2022 | 503.93 Mn |
| Dec 31, 2015 | -761.80 Mn |
| Dec 31, 2015 | -761.80 Mn |
| Sep 30, 2015 | -665.15 Mn |
| Sep 30, 2015 | -665.15 Mn |
| Jun 30, 2015 | -675.24 Mn |
| Jun 30, 2015 | -675.24 Mn |
| Dec 31, 2014 | -641.16 Mn |
| Dec 31, 2014 | -641.16 Mn |
| Sep 30, 2014 | 744.61 Mn |
| Sep 30, 2014 | 744.61 Mn |
| Jun 30, 2014 | 856.05 Mn |
| Jun 30, 2014 | 856.05 Mn |
| Dec 31, 2013 | 928.26 Mn |
| Dec 31, 2013 | 928.26 Mn |
| Sep 30, 2013 | 912.95 Mn |
| Sep 30, 2013 | 912.95 Mn |